Gilead Sciences, Inc. (GILD) stock
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 12/30102% above fair value
$168.98−1.28 (-0.75%)
Close on Nov 18, 2026Market cap $209.59BP/E –Yield 1.87%
Gilead Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Gilead Sciences's market cap was $210.63B on Nov 11, 2026, against $156.29B a year earlier. Over the last 5 years it ranged from $74.41B to $211.81B, with a median of $104.46B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $210.63B | +38.2% |
| 2025 | Dec 31, 2025 | $152.44B | +32.5% |
| 2024 | Dec 31, 2024 | $115.09B | +13.9% |
| 2023 | Dec 29, 2023 | $101.02B | -6.2% |
| 2022 | Dec 30, 2022 | $107.66B | +18.1% |
| 2021 | Dec 31, 2021 | $91.13B | +24.8% |
| 2020 | Dec 31, 2020 | $73.00B | -11.3% |
| 2019 | Dec 31, 2019 | $82.26B | +1.6% |
| 2018 | Dec 31, 2018 | $80.94B | -13.6% |
| 2017 | Dec 29, 2017 | $93.63B | -1.1% |
| 2016 | Dec 30, 2016 | $94.67B | -35.4% |
| 2015 | Dec 31, 2015 | $146.62B | +2.8% |
| 2014 | Dec 31, 2014 | $142.67B | +23.8% |
| 2013 | Dec 31, 2013 | $115.21B | +106.9% |
| 2012 | Dec 31, 2012 | $55.67B | +79.9% |
| 2011 | Dec 30, 2011 | $30.95B | +4.7% |
| 2010 | Dec 31, 2010 | $29.55B | -24.3% |
| 2009 | Dec 31, 2009 | $39.02B | – |
See a number that looks wrong?